NeuBase Therapeutics FY19 EPS $(0.45) Down From $(0.01) YoY

NeuBase Therapeutics (NASDAQ:NBSE) reported quarterly losses of $(0.45) per share. This is a 4400 percent decrease over losses of $(0.01) per share from the same period last year.

Benzinga · 01/09/2020 21:15

NeuBase Therapeutics (NASDAQ:NBSE) reported quarterly losses of $(0.45) per share. This is a 4400 percent decrease over losses of $(0.01) per share from the same period last year.